Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

BNGO holding history

Bionano Genomics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BNGO overviewAll 13F holders of BNGOFull Q2 2026 holdings

Shares (Q2 2026)
1,037
Value
$1.17K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BNGO by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,037$1.17K<0.1%+110+11.9%AddedHolders
Q1 2026927$1.08K<0.1%−1,297−58.3%ReducedHolders
Q4 20252,224$3.40K<0.1%−3,984−64.2%ReducedHolders
Q3 20256,208$10.6K<0.1%−5,447−46.7%ReducedHolders
Q2 202511,655$38.2K<0.1%−336−2.8%ReducedHolders
Q1 202511,991$33.5K<0.1%−521,045−97.8%ReducedHolders
Q4 2024533,036$153.7K<0.1%+507,329+1,973.5%AddedHolders
Q3 202425,707$11.7K<0.1%−5,512−17.7%ReducedHolders
Q2 202431,219$21.2K<0.1%−13,622−30.4%ReducedHolders
Q1 202444,841$49.8K<0.1%−37,432−45.5%ReducedHolders
Q4 202382,273$155.5K<0.1%+16,888+25.8%AddedHolders
Q3 202365,385$198.1K<0.1%−43,949−40.2%ReducedConverted for a 1-for-10 splitHolders
Q2 20231,093,339$666.9K<0.1%−1,872,095−63.1%ReducedHolders
Q1 20232,965,434$3.29M<0.1%−261,348−8.1%ReducedHolders
Q4 20223,226,782$4.71M<0.1%−117,195−3.5%ReducedHolders
Q3 20223,343,977$6.12M<0.1%+313,127+10.3%AddedHolders
Q2 20223,030,850$4.18M<0.1%+991,810+48.6%AddedHolders
Q1 20222,039,040$5.26M<0.1%+479,725+30.8%AddedHolders
Q4 20211,559,315$4.66M<0.1%+867,290+125.3%AddedHolders
Q3 2021692,025$3.81M<0.1%−975,953−58.5%ReducedHolders
Q2 20211,667,978$12.2M<0.1%+1,446,774+654.0%AddedHolders
Q1 2021221,204$1.79M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.